This article was originally published in The Gray Sheet
Board of directors authorizes the repurchase of up to 10 mil. shares of the company's common stock. "We view this new share repurchase authorization as a reflection of confidence in the long-term earnings and cash flow prospects for our business. This authorization is the largest in our history and underscores our commitment to increasing shareholder value," said company Chairman, President and CEO Clateo Castellini. Franklin Lakes, New Jersey-based Becton Dickinson repurchased about 5.2 mil. shares during its 1994 fiscal year (beginning Oct. 1, 1993)
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.